<DOC>
	<DOCNO>NCT00113308</DOCNO>
	<brief_summary>This study conduct find investigational drug call GW406381 help people rheumatoid arthritis .</brief_summary>
	<brief_title>COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Cyclooxygenase 2 Inhibitors</mesh_term>
	<criteria>Inclusion criterion : Rheumatoid arthritis ( RA ) least 12 month . Required nonsteroidal antiinflammatory drug ( NSAID ) COX2 inhibitor RA least 5 7 day week 4 week prior screen . Exclusion criterion : Any history cardiovascular disease ( e.g. , heart attack , stroke , congestive heart failure , uncontrolled high blood pressure ) , document peripheral arterial insufficiency symptomatic , clinically significant claudication , history peripheral arterial embolism . Have active stomach ulcer history stomach tear bleeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>COX-2 Inhibitor</keyword>
</DOC>